Loading...
XSHG
600436
Market cap16bUSD
Apr 03, Last price  
202.72CNY
1D
-0.21%
1Q
-1.35%
Jan 2017
342.91%
Name

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
P/E
43.72
P/S
12.16
EPS
4.64
Div Yield, %
1.14%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
16.11%
Revenues
10.06b
+15.69%
253,486,070418,820,927522,205,339593,069,218649,743,490694,749,846867,314,5831,021,565,7281,171,153,7381,395,868,5181,453,869,7711,885,674,6732,308,954,2693,713,953,9754,766,156,8935,722,273,4316,510,781,9578,021,550,4518,694,001,50410,058,497,338
Net income
2.80b
+13.15%
41,773,64986,398,28381,908,17595,188,986140,869,750129,663,236194,131,768254,867,961348,529,663429,768,408438,828,802466,676,722536,131,906807,018,6751,142,932,9171,374,376,8231,671,518,6672,431,899,9332,472,344,7312,797,351,515
CFO
2.21b
-67.89%
98,671,51669,055,60450,703,65460,038,07012,573,378129,519,043205,410,719232,950,354162,398,128274,336,209264,499,645305,510,311394,537,198676,933,316612,310,81801,467,076,541462,272,4046,873,030,5802,206,631,519
Dividend
Jun 07, 20242.32 CNY/sh

Profile

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
URL
https://www.zzpzh.com/
IPO date
Jun 16, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,058,497
15.69%
8,694,002
8.38%
Cost of revenue
6,288,398
5,490,271
Unusual Expense (Income)
NOPBT
3,770,099
3,203,730
NOPBT Margin
37.48%
36.85%
Operating Taxes
517,773
454,758
Tax Rate
13.73%
14.19%
NOPAT
3,252,326
2,748,972
Net income
2,797,352
13.15%
2,472,345
1.66%
Dividends
(784,638)
(730,014)
Dividend yield
0.54%
0.42%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
989,932
1,000,172
Long-term debt
250,020
217,593
Deferred revenue
17,667
17,010
Other long-term liabilities
86,390
82,825
Net debt
(9,565,034)
(1,975,491)
Cash flow
Cash from operating activities
2,206,632
6,873,031
CAPEX
(141,873)
Cash from investing activities
(2,798,612)
Cash from financing activities
(768,919)
FCF
8,402,017
(3,826,403)
Balance
Cash
10,173,010
2,496,426
Long term investments
631,976
696,830
Excess cash
10,302,061
2,758,556
Stockholders' equity
11,219,866
10,777,845
Invested Capital
4,855,157
10,166,352
ROIC
43.30%
40.30%
ROCE
24.82%
24.67%
EV
Common stock shares outstanding
602,877
603,317
Price
241.99
-16.11%
288.46
-34.01%
Market cap
145,890,322
-16.17%
174,032,882
-34.01%
EV
136,869,460
172,551,364
EBITDA
3,898,798
3,284,088
EV/EBITDA
35.11
52.54
Interest
37,307
38,007
Interest/NOPBT
0.99%
1.19%